The largest database of trusted experimental protocols

Hrp conjugated secondary antibody

Manufactured by GE Healthcare
Sourced in United Kingdom, United States, Germany, China, Italy, Japan

HRP-conjugated secondary antibodies are laboratory reagents used to detect and visualize primary antibodies in various immunoassays and immunohistochemical techniques. They consist of a secondary antibody molecule conjugated to the enzyme Horseradish Peroxidase (HRP), which catalyzes a colorimetric reaction for signal detection.

Automatically generated - may contain errors

278 protocols using hrp conjugated secondary antibody

1

Histone Modification Analysis in CD11b+ Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD11b+ cells from PBS injected or WGP-injected mice (24 h) were separated using CD11b microbeads (Miltenyi Biotech). Histone was extracted according to the manufacturer’s instruction (Active Motif, Inc.) and protein concentration was determined using Bradford quantification. Histone proteins were separated by SDS-PAGE 15% Tris-HCl gels and transferred onto PVDF membranes (Millipore). The membrane was blocked with 5% BSA at room temperature for 1 h and incubated overnight at 4 °C with primary antibodies including tri-methyl-histone H3 (lys4) rabbit mAb, acetyl-histone H3 (lys27) XP Rabbit mAb, tri-methyl-histone H3 (Lys27) Rabbit mAb, and histone H3 XP rabbit mAb (Cell Signaling Technology), then incubated with HRP-conjugated secondary antibodies (GE Healthcare) at room temperature for 1 h. The membrane was developed with Amersham ECL Prime Western Blotting Detection Reagent (GE Healthcare) and detected through Medical Film Processor (Konica Minolta Medical & Graphic). Precision Plus Protein Kaleidoscope Prestained Protein Standards were used as a standard protein marker (Bio-Rad).
+ Open protocol
+ Expand
2

Simvastatin Modulates Leiomyoma Stem Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Leiomyoma stem cells were treated with simvastatin (0.01, 0.1, 1 µM) or DMSO (vehicle control) for 48 h. Cells were lysed in a lysis buffer (radioimmunoprecipitation assay buffer, Sigma‐Aldrich) containing a protease and phosphatase inhibitor cocktail (Sigma‐Aldrich). An equal amount of protein lysates was loaded on 4 to 12% Bis‐Tris protein gradient gels (Thermo Fisher Scientific) and transferred to a nitrocellulose membrane (Thermo Fisher Scientific) using the mini trans‐blot transfer system (Thermo Fisher Scientific). To detect specific antigens, blots were probed with primary antibodies (Table S2) on a shaker at 4° C overnight, followed by 1 h of room temperature incubation with HRP conjugated secondary antibodies (GE Healthcare). Chemiluminescent Western blot signal was captured was using an Azure Imager c300 (Azure Biosystems). Band signals were quantified with the NIH ImageJ software (version 1.52r).
+ Open protocol
+ Expand
3

Assessing CD4 T Cell Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4 T cells were lysed in RIPA buffer containing Halt Protease inhibitor cocktail (Life Technologies). Soluble fractions of lysates were run on SDS–polyacrylamide gels and transferred to PVDF membranes. Membranes were blocked with 5% bovine serum albumin and incubated with the appropriate primary and HRP-conjugated secondary antibodies (GE Healthcare). Western Lightning ECL Pro (PerkinElmer) was used as the chemiluminescent substrate. For the acute stimulation experiment, naïve CD4 T cells were coated with 10 μg/mL anti-CD3 on ice for 10 min, washed and incubated at 37°C for various times in the presence of 50 μg/mL goat anti-hamster crosslinking antibody. Cells were quickly centrifuged and lysed as above in the presence of PhosphataseArrest I (G-Biosciences).
+ Open protocol
+ Expand
4

Immunoprecipitation and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed with lysis buffer (10 mM Hepes, 50 mM NaCl, 1 mM EDTA, 10% glycerol, 1% Triton, 30 mM NaF, and 1 mM Na3VO4) in the presence of protease inhibitor cocktail tablet (Sigma-Aldrich). For immunoprecipitation, lysates were incubated with Protein G Sepharose beads and the antibody overnight. Samples were boiled and separated to Tris-glycine SDS–PAGE and transferred onto polyvinylidene fluoride (PVDF) membranes. The membranes were incubated with the primary antibody and HRP-conjugated secondary antibodies (GE Healthcare). Immunoblots were visualized using the Amersham ECL Prime Western blotting detection reagent (GE Healthcare) and Bio-Rad ChemiDoc touch. The band intensity was measured by Image Lab software.
+ Open protocol
+ Expand
5

Protein Visualization in Serum-Free Media

Check if the same lab product or an alternative is used in the 5 most similar protocols
To visualize proteins in serum free condition media (SFM), 200 µl SFM were precipitated with 1 mL 96% EtOH at −20 °C for 1 hour. Precipitated protein was isolated following centrifugation at 12.000 rpm, at 4 °C for 15 minutes and dissolved in sample buffer. Proteins in cell lysates or in SFM were separated by SDS-PAGE, and blotted onto a PVDF membrane (Millipore). The membranes were dried and blocked in 2% Tween-20, followed by overnight incubation with primary antibodies in 20 mM Tris, 150 mM NaCl, containing 0,1% FCS and 0.1% Tween-20, pH 7.6 (TBS-T) at room temperature. Membranes were washed in TBS-T and incubated for 1 hour with HRP-conjugated secondary antibodies (GE healthcare), washed again in TBS-T, and developed using ECL-Prime (GE Healthcare). Images were acquired with an Image Quant LAS 4000. The L1-N14 antibody was from Santa Cruz Biotechnology, the c-myc 9E10 clone was from DSHB, the β-actin antibody was from Sigma Aldrich and the ADAM-10 antibody (ab1997) was from Abcam.
+ Open protocol
+ Expand
6

Western Blot Analysis of c-MYC Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole-cell lysates were prepared using RIPA buffer (Sigma-Aldrich) supplemented with Halt Protease and Phosphatase Inhibitor Mixture (Thermo Scientific). Samples were resolved on SDS/PAGE and transferred to Polyvinylidene fluoride (PVDF) membranes (BioRad, 1704156). The c-Myc antibody (9E10) (NB600-302, Novus Biologicals Bio-Techne, United Kingdom 1:2000) was used to identify c-MYC, while anti-β-actin (Santa Cruz, SC47778 1:10,000) was used as loading control. HRP-conjugated secondary antibodies were from GE Healthcare. Bands were detected using SuperSignal West Dura chemiluminescent substrate (Thermo Fisher Scientific, 34075) and images were obtained in a ChemiDoc XRS + (BioRad). Image processing was performed with ImageLab (Life Science Research, BioRad). All Western blot data are the result of three independent biological replicates. The quantification was performed by normalising to β-actin and the percentage of decrease in c-MYC in treated versus control cells was calculated.
+ Open protocol
+ Expand
7

SDS-PAGE and Western Blotting Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
SDS‐PAGE and subsequent western blotting analyses were performed as previously described.29 Cell lysates were prepared by solubilizing cells in radio‐immunoprecipitation assay (RIPA) buffer (50 mM Tris‐HCl [pH 7.5] containing 150 mM NaCl, 1% NP‐40, and 0.1% sodium deoxycholate) supplemented with protease‐inhibitor and phosphatase‐inhibitor cocktails (Sigma). Samples were then mixed at a 1:4 ration with 5 × sample buffer (300 mM Tris‐HCl [pH 6.8] containing 10% 2‐mercaptoethanol, 10% SDS, 50% glycerol and 0.05% Coomassie Brilliant Blue) and boiled for 5 min. The resulting samples (20 μg protein/lane) were subsequently separated by SDS‐PAGE using pre‐cast 5%–20% Tris‐glycine gradient gels (Atto Corporation, Tokyo, Japan) and transferred to PVDF membranes (Wako Pure Chemical). Membranes were blocked by incubation with TBS containing 0.1% Tween 20 (TBS‐T) and 5% skim milk (Megmilk Snow Bland, Tokyo, Japan) or BSA (Sigma) for 1 h, probed with the appropriate primary antibodies diluted with Can Get Signal Immunoreaction Enhancer Solution (Toyobo, Osaka, Japan) at 4°C, washed extensively with TBS‐T, and incubated with HRP‐conjugated secondary antibodies (1:5000 dilution) (GE Healthcare, Little Chalfont, UK). Finally, the membranes were washed, developed by incubation with ECL detection reagents (GE Healthcare) and exposed to Hyperfilm ECL (GE Healthcare).
+ Open protocol
+ Expand
8

Antibody Immunoblotting Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rabbit polyclonal CHD5 (sc-68390), rabbit polyclonal CHD4 (Bethyl 1:2000), and mouse monoclonal MYCN (1:5000; BD Biosciences) antibodies were used in this study. HRP conjugated secondary antibodies (1:3000) were from (GE Healthcare Life Sciences, Piscataway, NJ).
+ Open protocol
+ Expand
9

Synaptophysin and VGLUT1 Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total cells were lysed in 2% SDS, briefly sonicated and then incubated at 37 °C for 30 min with 1% 2-mercanptoethanol. After SDS-PAGE, samples were transferred to polyvinylidene difluoride membrane. The membranes were incubated in 5% Slim milk and 0.2% Tween-20, treated with primary antibodies and then probed with HRP-conjugated secondary antibodies (GE Healthcare) and chemiluminescent signals were acquired. Band intensities were measured using MultiGauge software (GE Healthcare) or ImageJ software (NIH). The ratio of synaptophysin 1 or VGLUT1 to β-III-tubulin were acquired and normalized to the value of control.
+ Open protocol
+ Expand
10

Protein Phosphorylation Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were treated with the various drugs and then lysed as described previously.18, 21 To prevent post‐lysis changes in phosphorylation, 50 mM NaF and 1.68 mM Na3VO4 were added. After centrifugation (11700 g for 10 min), the protein concentrations of lysates were evaluated by the Bradford method, and sample buffer containing 5% 2‐mercaptoethanol was added. After boiling for 5 min, 20‐μg samples were separated by sodium dodecyl sulphate polyacrylamide gel electrophoresis, transferred to polyvinylidene difluoride membranes, and blocked with 5% skim milk in TBS‐tween buffer (50 mM Tris‐HCL [pH 7.4], 150 mM NaCl and 0.05% Tween 20). Immunoblotting was performed using primary antibodies appropriately diluted in TBS‐tween buffer containing 5% BSA and 0.05% sodium azide (Table S1). HRP conjugated secondary antibodies (GE Healthcare, Little Chalfont, UK) were added and activated with Immobilon Western Substrate (Millipore, Billerica, MA, USA). Images were obtained using a LAS 4000mini bio‐imager (Fujifilm, Tokyo, Japan) and analyzed with MultiGauge software (Fujifilm).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!